SCHEMBL843875

SCHEMBL843875

CC(O)C1CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24271678 0.87
SCHEMBL1499862 0.87
SCHEMBL29017460 0.85
SCHEMBL18840273 0.85
SCHEMBL19193850 0.79
Propanol SCHEMBL28037773 0.76 ALDH1A1 (0.35)
SCHEMBL25081821 0.76 HRH3 (0.32)
SCHEMBL777224 0.75
SCHEMBL22980948 0.75
SCHEMBL8383143 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022199-A1 CYANOTRIAZOLE COMPOUNDS Otsuka Pharmaceutical Co., Ltd. (JP) 2016-05-25 EP disclosed
EP-2673324-B1 INK SET, CARTRIDGE, INKJET RECORDING METHOD, AND INKJET RECORDING DEVICE RICOH CO LTD (JP) 2015-07-29 EP disclosed
WO-2015008872-A1 CYANOTRIAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-01-22 WO disclosed
US-8513471-B2 Process for the manufacture of polyol perfluoropolyether derivative SOLVAY SOLEXIS S.P.A. (IT) 2013-08-20 US disclosed
EP-1605021-B1 RADIATION CURABLE COMPOSITION, OPTICAL WAVEGUIDE AND METHOD FOR FORMATION THEREOF JSR CORP (JP) 2012-08-29 EP disclosed
US-20120184652-A1 CURABLE RESINS AND ARTICLES MADE THEREFROM DIGITALOPTICS CORPORATION EAST (US) 2012-07-19 US disclosed
US-20120178859-A1 CURABLE RESINS AND ARTICLES MADE THEREFROM DIGITALOPTICS CORPORATION EAST (US) 2012-07-12 US disclosed
EP-2197939-B1 PROCESS FOR THE MANUFACTURE OF POLYOL PERFLUOROPOLYETHER DERIVATIVE SOLVAY SPECIALTY POLYMERS IT (IT) 2012-07-11 EP disclosed
US-8197723-B2 Curable resins and articles made therefrom DIGITALOPTICS CORPORATION EAST (US) 2012-06-12 US disclosed
EP-2440601-A2 CURABLE RESINS AND ARTICLES MADE THEREFROM Digitaloptics Corporation East (US) 2012-04-18 EP disclosed
WO-2008101840-A1 COMBINATION OF ERLOTINIB AND MEK-INHIBITORS FOR INHIBITING PROLIFERATION OF TUMOR CELLS F. HOFFMANN-LA ROCHE AG (CH) 2008-08-28 WO disclosed
US-20080207563-A1 METHOD FOR INHIBITING PROLIFERATION OF TUMOR CELLS NIU HUIFENG 2008-08-28 US disclosed
WO-2007096259-A1 HYDANTOIN BASED KINASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2007-08-30 WO disclosed
US-20070197617-A1 Substituted hydantoins CHEN SHAOQING 2007-08-23 US disclosed
US-7162131-B2 Radiation-curable composition, optical waveguide and method for formation thereof JSR CORPORATION (JP) 2007-01-09 US disclosed
CN-1867554-A Piperazine with ortho-substituted phenyl and its use as GLYT1 inhibitors HOFFMANN LA ROCHE (CH) 2006-11-22 CN disclosed
US-20060165362-A1 Radiation curable composition, optical waveguide and method for formation thereof JSR CORPORATION (JP) 2006-07-27 US disclosed
US-20060009562-A1 Cationically polymerizable composition containing metal oxide partricles TOAGOSEI CO., LTD. (JP) 2006-01-12 US disclosed
EP-1605021-A1 RADIATION CURABLE COMPOSITION, OPTICAL WAVEGUIDE AND METHOD FOR FORMATION THEREOF JSR Corporation (JP) 2005-12-14 EP disclosed
WO-2001070227-A1 ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE MERCK & CO., INC. (US) 2001-09-27 WO disclosed